Literature DB >> 15542056

Mitochondrial and nuclear DNA damage induced by 5-aminolevulinic acid.

Janice Onuki1, Yiming Chen, Priscila C Teixeira, Robert I Schumacher, Marisa H G Medeiros, Bennett Van Houten, Paolo Di Mascio.   

Abstract

5-Aminolevulinic acid (ALA) is a heme precursor accumulated in plasma and in organs in acute intermittent porphyria (AIP), a disease associated with neuromuscular dysfunction and increased incidence of hepatocellular carcinoma (HCC). Liver biopsies of AIP patients showed odd-shaped mitochondria and autophagic vacuoles containing well-preserved mitochondria. ALA yields reactive oxygen species upon metal-catalyzed oxidation and causes in vivo and in vitro impairment of rat liver mitochondria and DNA damage. Using a quantitative polymerase chain reaction assay, we demonstrated that ALA induces a dose-dependent damage in nuclear and mitochondrial DNA in human SVNF fibroblasts and rat PC12 cells. CHO cells treated with ALA also show nuclear DNA damage and human HepG2 cells entered in apoptosis and necrosis induced by ALA and its dimerization product, DHPY. The present data provide additional information on the genotoxicity of ALA, reinforcing the hypothesis that it may be involved in the development of HCC in AIP patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15542056     DOI: 10.1016/j.abb.2004.09.030

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  21 in total

1.  Effect of 5-aminolevulinic acid on the expression of carcinogenesis-related proteins in cultured primary hepatocytes.

Authors:  P R Menezes; C B González; A O DeSouza; D A Maria; J Onuki
Journal:  Mol Biol Rep       Date:  2018-09-14       Impact factor: 2.316

Review 2.  DNA damage and autophagy.

Authors:  Humberto Rodriguez-Rocha; Aracely Garcia-Garcia; Mihalis I Panayiotidis; Rodrigo Franco
Journal:  Mutat Res       Date:  2011-03-17       Impact factor: 2.433

3.  Intra-operative acidosis during 5-aminolevulinic acid assisted glioma resection.

Authors:  Ian Anderson; Thomas Naylor; Justin McKinlay; Gnanamurthy Sivakumar
Journal:  BMJ Case Rep       Date:  2015-04-24

Review 4.  Murine models of the human porphyrias: Contributions toward understanding disease pathogenesis and the development of new therapies.

Authors:  Makiko Yasuda; Robert J Desnick
Journal:  Mol Genet Metab       Date:  2019-01-18       Impact factor: 4.797

5.  Homozygous hydroxymethylbilane synthase knock-in mice provide pathogenic insights into the severe neurological impairments present in human homozygous dominant acute intermittent porphyria.

Authors:  Makiko Yasuda; Lin Gan; Brenden Chen; Chunli Yu; Jinglan Zhang; Miguel A Gama-Sosa; Daniela D Pollak; Stefanie Berger; John D Phillips; Winfried Edelmann; Robert J Desnick
Journal:  Hum Mol Genet       Date:  2019-06-01       Impact factor: 6.150

Review 6.  Lead, Arsenic, and Manganese Metal Mixture Exposures: Focus on Biomarkers of Effect.

Authors:  V M Andrade; M L Mateus; M C Batoréu; M Aschner; A P Marreilha dos Santos
Journal:  Biol Trace Elem Res       Date:  2015-02-20       Impact factor: 3.738

7.  5-Aminolevulinic acid-based photodynamic therapy suppressed survival factors and activated proteases for apoptosis in human glioblastoma U87MG cells.

Authors:  Surajit Karmakar; Naren L Banik; Sunil J Patel; Swapan K Ray
Journal:  Neurosci Lett       Date:  2007-02-11       Impact factor: 3.046

8.  The heme precursor delta-aminolevulinate blocks peripheral myelin formation.

Authors:  Natalia Felitsyn; Colin McLeod; Albert L Shroads; Peter W Stacpoole; Lucia Notterpek
Journal:  J Neurochem       Date:  2008-07-04       Impact factor: 5.372

Review 9.  Porphyric Neuropathy: Pathophysiology, Diagnosis, and Updated Management.

Authors:  Mohamed Kazamel; Robert J Desnick; John G Quigley
Journal:  Curr Neurol Neurosci Rep       Date:  2020-10-07       Impact factor: 5.081

10.  Altered gene expression and DNA damage in peripheral blood cells from Friedreich's ataxia patients: cellular model of pathology.

Authors:  Astrid C Haugen; Nicholas A Di Prospero; Joel S Parker; Rick D Fannin; Jeff Chou; Joel N Meyer; Christopher Halweg; Jennifer B Collins; Alexandra Durr; Kenneth Fischbeck; Bennett Van Houten
Journal:  PLoS Genet       Date:  2010-01-15       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.